NCT03674372View on ClinicalTrials.gov

Fetoscopic Endoluminal Tracheal Occlusion

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 16, 2018

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2030

Conditions
Congenital Diaphragmatic Hernia
Interventions
DEVICE

Fetoscopic Endoluminal Tracheal Occlusion (FETO)

This study will position and remove an endoluminal tracheal balloon in utero (FETO) to study the feasibility of implementing FETO therapy in the most severe group of fetuses with left CDH (O/E \< 25%; O/E LHR \< 30 %) and right CDH (O/E LHR \< 45%).

Trial Locations (1)

80045

RECRUITING

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER